Logo image
Sign in
A phase 2 basket study of tucatinib and trastuzumab in solid tumors with human epidermal growth factor receptor 2 alterations: Uterine and cervical cancer cohorts (SGNTUC-019, trial in progress) (1261)
Journal article   Peer reviewed

A phase 2 basket study of tucatinib and trastuzumab in solid tumors with human epidermal growth factor receptor 2 alterations: Uterine and cervical cancer cohorts (SGNTUC-019, trial in progress) (1261)

Bradley Monk, Fan Jin, Jorge Ramos, Qianwen Tan and David O'Malley
Gynecologic oncology, Vol.176, pp.S165-S166
09/2023

Metrics

12 Record Views

Details